Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 451-900-9 | CAS number: 894406-76-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.19 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 3.2
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 7 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Route to route extrapolation according to ECHA Guidance CSR R.8 (2010)
- AF for dose response relationship:
- 1
- Justification:
- Default AF
- AF for differences in duration of exposure:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Therefore, increasing exposure duration does not increase the incidence or severity of such adverse effects (ECHA guidance CSR R.8, 2010).
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Since local effects are independent of the basal metabolic rate, allometric scaling should not be applied (ECHA guidance CSR R.8, 2010).
- AF for other interspecies differences:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. No kinetic assessment factors are proposed for interspecies variability as the local toxicity caused by the test substance is the result of direct chemical reactivity and no kinetic processes are involved
- AF for intraspecies differences:
- 3.2
- Justification:
- AF for potential intraspecies toxicodynamic effects
- AF for the quality of the whole database:
- 1
- Justification:
- Good quality database
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties identified
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.19 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 7 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Route to route extrapolation according to ECHA Guidance CSR R.8 (2010)
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.75 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Dermal
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 3.2
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 12 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- Default AF
- AF for differences in duration of exposure:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Therefore, increasing exposure duration does not increase the incidence or severity of such adverse effects (ECHA guidance CSR R.8, 2010).
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Since local effects are independent of the basal metabolic rate, allometric scaling should not be applied (ECHA guidance CSR R.8, 2010).
- AF for other interspecies differences:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. No kinetic assessment factors are proposed for interspecies variability as the local toxicity caused by the test substance is the result of direct chemical reactivity and no kinetic processes are involved
- AF for intraspecies differences:
- 3.2
- Justification:
- AF for potential intraspecies toxicodynamic effects
- AF for the quality of the whole database:
- 1
- Justification:
- Good quality database
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties identified
Acute/short term exposure
- Hazard assessment conclusion:
- no DNEL required: short term exposure controlled by conditions for long-term
- Value:
- 3.75 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Dermal
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.002 mg/cm²
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 6.4
- Dose descriptor:
- other: LOAEL
- AF for dose response relationship:
- 2
- Justification:
- AF for extrapolation from a LOAEL
- AF for differences in duration of exposure:
- 1
- Justification:
- The test substance is irritating/corrosive. Increasing exposure duration does not increase the incidence or severity of such adverse effects (ECHA guidance CSR R.8, 2010).
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- The test substance is irritating/corrosive. Since local effects are independent of the basal metabolic rate, allometric scaling should not be applied (ECHA guidance CSR R.8, 2010).
- AF for other interspecies differences:
- 1
- Justification:
- The test substance is irritating/corrosive. No kinetic assessment factors are proposed for interspecies variability as the local toxicity caused by the test substance is the result of direct chemical reactivity and no kinetic processes are involved
- AF for intraspecies differences:
- 3.2
- Justification:
- AF for potential intraspecies toxicodynamic effects
- AF for the quality of the whole database:
- 1
- Justification:
- Good quality database
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties identified
Acute/short term exposure
- Hazard assessment conclusion:
- no DNEL required: short term exposure controlled by conditions for long-term
- Value:
- 0.002 mg/cm²
- Most sensitive endpoint:
- repeated dose toxicity
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - workers
See discussion below.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.94 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 3.2
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 3 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Route to route extrapolation according to ECHA Guidance CSR R.8 (2010)
- AF for dose response relationship:
- 1
- Justification:
- Default AF
- AF for differences in duration of exposure:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Therefore, increasing exposure duration does not increase the incidence or severity of such adverse effects (ECHA guidance CSR R.8, 2010).
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Since local effects are independent of the basal metabolic rate, allometric scaling should not be applied (ECHA guidance CSR R.8, 2010).
- AF for other interspecies differences:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. No kinetic assessment factors are proposed for interspecies variability as the local toxicity caused by the test substance is the result of direct chemical reactivity and no kinetic processes are involved
- AF for intraspecies differences:
- 3.2
- Justification:
- AF for potential intraspecies toxicodynamic effects
- AF for the quality of the whole database:
- 1
- Justification:
- Good quality database
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties identified
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.94 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 3 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Route to route extrapolation according to ECHA Guidance CSR R.8 (2010)
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.75 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Dermal
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 3.2
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 12 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- Default AF
- AF for differences in duration of exposure:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Therefore, increasing exposure duration does not increase the incidence or severity of adverse effects (ECHA guidance CSR R.8, 2010).
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Since local effects are independent of the basal metabolic rate, allometric scaling should not be applied (ECHA guidance CSR R.8, 2010).
- AF for other interspecies differences:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. No kinetic assessment factors are proposed for interspecies variability as the local toxicity caused by the test substance is the result of direct chemical reactivity and no kinetic processes are involved
- AF for intraspecies differences:
- 3.2
- Justification:
- AF for potential intraspecies toxicodynamic effects
- AF for the quality of the whole database:
- 1
- Justification:
- Good quality database
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties identified
Acute/short term exposure
- Hazard assessment conclusion:
- no DNEL required: short term exposure controlled by conditions for long-term
- Value:
- 3.75 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Dermal
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.002 mg/cm²
- Most sensitive endpoint:
- skin irritation/corrosion
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 6.4
- Dose descriptor:
- other: NOAEL
- AF for dose response relationship:
- 2
- Justification:
- AF for extrapolation from a LOAEL
- AF for differences in duration of exposure:
- 1
- Justification:
- The test substance is irritating/corrosive. Therefore, increasing exposure duration does not increase the incidence or severity of such adverse effects (ECHA guidance CSR R.8, 2010).
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- The test substance is irritating/corrosive. Since local effects are independent of the basal metabolic rate, allometric scaling should not be applied (ECHA guidance CSR R.8, 2010).
- AF for other interspecies differences:
- 1
- Justification:
- The test substance is irritating/corrosive. No kinetic assessment factors are proposed for interspecies variability as the local toxicity caused by the test substance is the result of direct chemical reactivity and no kinetic processes are involved
- AF for intraspecies differences:
- 3.2
- Justification:
- AF for potential intraspecies toxicodynamic effects
- AF for the quality of the whole database:
- 1
- Justification:
- Good quality database
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties identified
Acute/short term exposure
- Hazard assessment conclusion:
- no DNEL required: short term exposure controlled by conditions for long-term
- Value:
- 0.002 mg/cm²
- Most sensitive endpoint:
- skin irritation/corrosion
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.31 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 3.2
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- Default AF
- AF for differences in duration of exposure:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Therefore, increasing exposure duration does not increase the incidence or severity of adverse effects (ECHA guidance CSR R.8, 2010).
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. Since local effects are independent of the basal metabolic rate, allometric scaling should not be applied (ECHA guidance CSR R.8, 2010).
- AF for other interspecies differences:
- 1
- Justification:
- Systemic effects are secondary to local irritation/corrosion caused by the test substance. No kinetic assessment factors are proposed for interspecies variability as the local toxicity caused by the test substance is the result of direct chemical reactivity and no kinetic processes are involved
- AF for intraspecies differences:
- 3.2
- Justification:
- AF for potential intraspecies toxicodynamic effects
- AF for the quality of the whole database:
- 1
- Justification:
- Good quality database
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties identified
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.31 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - General Population
Oral repeated dose studies have been conducted using the structurally-related substance Didecyldimethylammonium chloride (DDAC) in rats, mice and dogs. The read-across between DDACarbonate and DDAC is justified. Further to the repeated dose toxicity studies two developmental toxicity studies using DDAC are available. The NOAEL for maternal toxicity revealed in the key developmental study was determined to be 1.0 mg/kg bw/day. The observed adverse effects at higher concentrations were considered to be either the result of or a consequence of local irritation. This worst-case NOAEL is used for oral DNEL derivation.
A standard dermal sub-chronic repeated dose toxicity study is available using the structural analog DDAC. The systemic NOAEL of 12 mg AI/kg bw/day was used for systemic DNEL derivation. The LOAEC of 0.01 mg/cm2/day based on slight and reversible local toxicity effects is used for DNEL derivation. The results for local toxicity observed are supported by a non-standard repeated exposure toxicity test using DDACarbonate (21-Day Repeated Dose Dermal Irritation Study in Female Rats).
No studies assessing the effect of inhalation exposure are available. However, further data are not required as appropriate risk mitigation measures can be employed to prevent inhalation exposure. Route-to-route extrapolation was carried out for risk assessment purposes.
A standard study on skin irritation was carried out. The study was conducted to assess the potential of a 50 % active ingredient formulation of the test material to cause irritation after one topical application to the skin of a New Zealand White male rabbit for four hours. The test item was considered to be corrosive in this skin irritation test. Therefore, testing for eye irritation was waived.
Toxicity of DDACarbonate and the structural analog DDAC are characterized by severe irritation and primary tissue damage by corrosion at the site of application (e.g. skin and gastrointestinal tract) in all species and via all exposure routes tested. Systemic effects are secondary to primary local effects observed. No data are available to assess the relative sensitivities of humans to these local effects compared to experimental animals.
No kinetic assessment factors are proposed for interspecies variability in deriving the DNEL-values, because the local toxicity caused by DDACarbonate is the result of direct chemical reactivity and no kinetic processes are involved (ECHA Guideline CSR R.8, 2010). Similarly, no dynamic interspecies assessment factors are proposed as humans are not considered to be more susceptible to the local effects on the skin and the gastrointestinal tract compared to animals.
DDACarbonate is a cationic surfactant type active substance that reacts directly with the cell walls of microorganisms. This mode of action is most likely to be the underlying mechanism of the observed local toxicity of DDAC/DDACarbonate in mammals. Hence, it is considered that the local toxicity of DDACarbonate is the result of the direct interaction of DDACarbonate with the external membranes of the skin and gastrointestinal tract. In addition it is not considered necessary to include a toxicokinetic factor to account for intraspecies variability because the local effects observed in the animals exposed to DDAC/DDACarbonate do not involve kinetic and metabolic processes. In line with previous assessments only, a toxicodynamic assessment factor of 3.2 for intraspecies variability is proposed (UK MSCA (2012) Assessment Report for the Inclusion of Active Substances in Annex I to Directive 98/8/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.